Indivior (NASDAQ:INDV) Sees Strong Trading Volume

Shares of Indivior PLC (NASDAQ:INDV) saw an uptick in trading volume on Monday . 267,165 shares were traded during trading, an increase of 15% from the previous session’s volume of 232,865 shares.The stock last traded at $12.71 and had previously closed at $12.79.

Wall Street Analyst Weigh In

Several research firms have commented on INDV. Craig Hallum lowered their price objective on shares of Indivior from $37.00 to $24.00 and set a “buy” rating for the company in a research report on Wednesday, July 10th. Piper Sandler began coverage on shares of Indivior in a research report on Tuesday, July 23rd. They set an “overweight” rating and a $22.00 price objective for the company.

Indivior Trading Up 2.0 %

The firm has a market cap of $1.80 billion, a PE ratio of 1,279.00 and a beta of 0.69. The company has a quick ratio of 0.68, a current ratio of 0.85 and a debt-to-equity ratio of 23.50. The company’s 50 day moving average price is $15.09 and its two-hundred day moving average price is $17.66.

Indivior (NASDAQ:INDV) last announced its earnings results on Thursday, April 25th. The company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.01). Indivior had a negative net margin of 12.29% and a negative return on equity of 654.82%. The firm had revenue of $284.00 million during the quarter, compared to analysts’ expectations of $300.00 million. As a group, sell-side analysts forecast that Indivior PLC will post 1.8 EPS for the current year.

Institutional Investors Weigh In On Indivior

Hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp purchased a new stake in shares of Indivior in the second quarter valued at $188,000. Chilton Investment Co. Inc. purchased a new position in Indivior in the 4th quarter worth about $263,000. ADAR1 Capital Management LLC purchased a new position in Indivior in the 4th quarter worth about $368,000. Cannon Global Investment Management LLC purchased a new position in Indivior in the 1st quarter worth about $563,000. Finally, Campbell & CO Investment Adviser LLC increased its stake in Indivior by 2.8% in the 4th quarter. Campbell & CO Investment Adviser LLC now owns 37,948 shares of the company’s stock worth $573,000 after buying an additional 1,037 shares during the period. Hedge funds and other institutional investors own 60.33% of the company’s stock.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.